These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y; Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948 [TBL] [Abstract][Full Text] [Related]
5. Morphological characteristics of lateral pelvic lymph nodes in rectal carcinoma. Matsuoka H; Masaki T; Sugiyama M; Atomi Y; Ohkura Y; Sakamoto A Langenbecks Arch Surg; 2007 Sep; 392(5):543-7. PubMed ID: 17380345 [TBL] [Abstract][Full Text] [Related]
6. Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. Matsuoka H; Nakamura A; Masaki T; Sugiyama M; Nitatori T; Ohkura Y; Sakamoto A; Atomi Y Anticancer Res; 2007; 27(5B):3529-33. PubMed ID: 17972513 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of Two-Dimensional Values Measured Using Preoperative Multidetector Computed Tomography in Predicting Lymph Node Metastasis of Gastric Cancer. Lee SL; Lee HH; Ku YM; Jeon HM Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S786-93. PubMed ID: 25986871 [TBL] [Abstract][Full Text] [Related]
8. Correlations between the sizes of lateral pelvic lymph nodes and metastases in rectal cancer patients treated with preoperative chemoradiotherapy. Ishihara S; Kawai K; Tanaka T; Hata K; Nozawa H ANZ J Surg; 2018 Dec; 88(12):1306-1310. PubMed ID: 29974631 [TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367 [TBL] [Abstract][Full Text] [Related]
10. [Lateral pelvic lymph node metastasis is an important prognostic factor for low rectal cancer]. Pan YS; Wan YL; Liu YC; Wang X; Wu T Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):984-7. PubMed ID: 19957807 [TBL] [Abstract][Full Text] [Related]
11. Selection of Lymph Node-Positive Cases Based on Perirectal and Lateral Pelvic Lymph Nodes Using Magnetic Resonance Imaging: Study of the Japanese Society for Cancer of the Colon and Rectum. Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Kameoka S; Sugihara K Ann Surg Oncol; 2016 Apr; 23(4):1187-94. PubMed ID: 26671038 [TBL] [Abstract][Full Text] [Related]
12. Preoperative chemoradiotherapy changes the size criterion for predicting lateral lymph node metastasis in lower rectal cancer. Yamaoka Y; Kinugasa Y; Shiomi A; Yamaguchi T; Kagawa H; Yamakawa Y; Numata M; Furutani A Int J Colorectal Dis; 2017 Nov; 32(11):1631-1637. PubMed ID: 28762190 [TBL] [Abstract][Full Text] [Related]
13. Analysis of lymph node metastatic pattern according to the depth of in-growth in the muscularis propria in T2 rectal cancer for lateral lymph node dissection. Komori K; Kanemitsu Y; Ishiguro S; Shimizu Y; Sano T; Kato T Dig Surg; 2011; 28(5-6):352-9. PubMed ID: 22042151 [TBL] [Abstract][Full Text] [Related]
14. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Ueno M; Oya M; Azekura K; Yamaguchi T; Muto T Br J Surg; 2005 Jun; 92(6):756-63. PubMed ID: 15838895 [TBL] [Abstract][Full Text] [Related]
15. Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI. Ogawa S; Itabashi M; Hirosawa T; Hashimoto T; Bamba Y; Kameoka S J Surg Oncol; 2014 Mar; 109(3):227-33. PubMed ID: 24165955 [TBL] [Abstract][Full Text] [Related]
16. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212). Komori K; Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Shiomi A; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Kinugasa Y; Takii Y; Akasu T; Moriya Y; Eur J Surg Oncol; 2019 Mar; 45(3):336-340. PubMed ID: 30477950 [TBL] [Abstract][Full Text] [Related]
17. Indication and benefit of pelvic sidewall dissection for rectal cancer. Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749 [TBL] [Abstract][Full Text] [Related]
18. Is total mesorectal excision always necessary for T1-T2 lower rectal cancer? Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Saito Y; Watanabe M; Morita T; Hida J; Ueno M; Ono M; Yasuno M; Sugihara K Ann Surg Oncol; 2010 Apr; 17(4):973-80. PubMed ID: 19953330 [TBL] [Abstract][Full Text] [Related]
19. Prediction of metastasis to mesorectal, internal iliac and obturator lymph nodes according to size criteria in patients with locally advanced lower rectal cancer. Hatano S; Ishida H; Ishiguro T; Kumamoto K; Ishibashi K; Mochiki E; Tamaru J Jpn J Clin Oncol; 2015 Jan; 45(1):35-42. PubMed ID: 25324477 [TBL] [Abstract][Full Text] [Related]
20. Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer. Lee D; Matsuda T; Yamashita K; Hasegawa H; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Fukumoto T; Kakeji Y Anticancer Res; 2019 Feb; 39(2):993-998. PubMed ID: 30711986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]